Overview

Study of 0416 Ointment in the Treatment of Atopic Dermatitis

Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
0
Participant gender:
All
Summary
The aim of this trial is to assess the efficacy of 0416 Ointment in the Treatment of Atopic Dermatitis. Treatment medication will be administered as follows: Apply a thin layer of ointment to affected skin areas twice daily and rub in gently and completely. Study medication will be applied twice a day, approximately 12 hours apart, for approximately 2 weeks.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Fougera Pharmaceuticals Inc.
Treatments:
Tacrolimus
Criteria
Inclusion Criteria:

- Clinical diagnosis of Atopic Dermatitis

- Good health with the exception of Atopic Dermatitis

- Percent Body Surface Area minimum requirements

Exclusion Criteria:

- Subjects who are pregnant, nursing, or planning a pregnancy within the study
participation period.

- Subjects who have any systemic or dermatological disorders with the exception of
Atopic Dermatitis